Trial analysis reveals almost all adults with hypertensive chronic kidney disease would benefit from intensive blood pressure lowering
2025-11-07
(Press-News.org) Houston, TX (November 7, 2025) — An analysis of the Systolic Blood Pressure Intervention Trial (SPRINT) indicates that nearly all adults with chronic kidney disease (CKD) would have benefits that outweigh the harm from a systolic blood pressure target of <120 mm Hg compared with a target of <140 mm Hg. Thefindings will be presented at ASN Kidney Week 2025 November 5– 9.
In a benefit-harm trade-off analysis of 2,012 participants with CKD, investigators found that when predicting individualized treatment effects for multiple outcomesand simulating preferences for participants who view the benefits of intensive blood pressure lowering (reductions in death, cardiovascular events, and cognitive impairment) as much more important than treatment-related harms (such as emergency room visits or hospitalizations for acute kidney injury and fainting), 100% had a positive net benefit favoring intensive blood pressure lowering. When simulating benefits and harms to have similar, intermediate importance, 9 out of 10 still had a positive net benefit.
Compared with people with earlier-stage CKD (estimated glomerular filtration rate(45–59 ml/min/1.73m2), people with more advanced CKD (20–44 ml/min/1.73m2) experienced more treatment-related harms from a lower systolic blood pressure goal; however, they also had larger benefits, which resulted in the more advanced CKD group having greater net benefits. The findings, which are consistent with KDIGO Guidelines that recommend a systolic blood pressure target of <120 mm Hg for adults with hypertension and CKD, could help patients and care partnersovercome therapeutic inertia that commonly occurs with intensifying blood pressure control in adults with CKD.
“This study demonstrates that evidence about blood pressure targets from SPRINT can be personalized to adults with hypertension and CKD by using each individual's estimated risks and preferences for multiple outcomes related to bloodpressure lowering, which could help facilitate shared decision-making conversations,” said corresponding author Alan Vera, a medical student at the University of California Davis.
Study: “Individualized Net Benefit of Intensive Blood Pressure Lowering AmongPersons with CKD in SPRINT”
Join ASN and approximately 12,000 other kidney professionals from across the globe at Kidney Week 2025 in Houston, TX. The world's premier nephrology meeting, Kidney Week, provides participants with exciting and challenging opportunities to exchange knowledge, learn the latest scientific and medical advances, and listen to engaging andprovocative discussions with leading experts in the field. Early programs begin on November 5, followed by the Annual Meeting from November 6-9. Follow the conversation at #KidneyWk.
About the American Society of Nephrology (ASN)
Since 1966, ASN has been leading the fight to prevent, treat, and cure kidney diseasesthroughout the world by educating health professionals and scientists, advancing research and innovation, communicating new knowledge and advocating for the highest quality care for patients. ASN has nearly 22,000 members representing 141 countries. For more information, visit www.asn- online.org and follow us on Facebook, X, LinkedIn, and Instagram.
# # #
END
ELSE PRESS RELEASES FROM THIS DATE:
2025-11-07
A husband’s optimism and confidence may play a crucial, if often unseen, role in helping babies arrive healthy and on time.
A new study from University of California Merced psychology researchers found that when married fathers reported higher levels of resilience — a quality that includes traits such as optimism, self-esteem, and perceived social support — their partners showed lower levels of inflammation during pregnancy and carried their babies longer.
“This is one of the first studies to show that a father’s inner strengths, such as his optimism and ability to cope with challenges, can ripple through the family in measurable, ...
2025-11-07
MSU has a satellite uplink/LTN TV studio and Comrex line for radio interviews upon request.
Images
EAST LANSING, Mich. – To mark the 250th anniversary of the Declaration of Independence next July, Michigan State University’s James Madison College has plans to launch summer programs for Michigan high school students and teachers that explore America’s founding principles.
A three-year grant, totaling $1.3 million from the U.S. Department of Education, will fund the James Madison College Academy for Civic Education, or ACE, offering intensive seminars built around primary sources like the U.S. Constitution, Federalist Papers, works ...
2025-11-07
University of Phoenix College of Doctoral Studies announces the publication of a new white paper, “Recovering from Burnout Through Mentoring,” authored by Carla M. Harris, Ed.D., and Sandra Sessoms-Penny, Ed.D, both Fellows at the University of Phoenix Center for Organizational Wellness, Engagement, and Belonging (CO-WEB). The paper examines how structured mentorship can support employees experiencing burnout and offers actionable guidance for organizations and leaders to foster resilience and engagement.
Grounded in current research and insights from the University’s Career Optimism Index® study, the authors note that employee burnout ...
2025-11-07
UNIVERSITY PARK, Pa. — In the dense forests of northwestern Pennsylvania, hundreds of thousands of retired oil and gas wells — some dating back to the mid-1800s, long before modern construction standards — dot the landscape, according to geochemists in Penn State’s College of Earth and Mineral Sciences who recently led a study in the region. Left uncapped and exposed to air and erosion, they break down, leaching harmful chemicals into the atmosphere and, the researchers reported, into the groundwater.
Led by Susan L. Brantley, ...
2025-11-07
East Hanover, NJ – Nov. 7, 2025 – John DeLuca, PhD, of Kessler Foundation received the 2025 Reitan Clinical Excellence Award from the National Academy of Neuropsychology (NAN) at its annual conference today. This honor recognizes individuals who have made significant contributions to the clinical practice of neuropsychology, influencing methods, settings, and training in ways that benefit both the profession and its clients.
Dr. DeLuca is senior vice president of Research and Training at the Foundation and a recognized leader in the field of neuropsychology. ...
2025-11-07
About The Study: In the Chronic Kidney Disease Prognosis Consortium, 11% of outpatient participants and 35% of hospitalized patients had a cystatin C–based estimated glomerular filtration rate (eGFRcys) that was at least 30% lower than their creatinine-based eGFR (eGFRcr). In the outpatient setting, presence of eGFRcys at least 30% lower than eGFRcr was associated with significantly higher rates of all-cause mortality, cardiovascular events, and kidney failure.
Corresponding Authors: To contact the corresponding authors, email Morgan E. Grams, ...
2025-11-07
A mismatch between two common tests for kidney function may indicate a higher risk for kidney failure, heart disease, and death, a new study shows.
Health care providers for decades have measured blood levels of the molecule creatinine to track the rate at which kidneys filter waste from muscle breakdown in the bloodstream. According to more recent guidelines, levels of cystatin C, a small protein made by all cells in the body, can also be used to measure kidney function. Since these two tests are influenced by different factors — including some related to disease or aging — using both markers together can provide a better measure of kidney function and risk of organ ...
2025-11-07
The American College of Cardiology (ACC) and OpenEvidence are entering a strategic partnership to accelerate the translation of cardiovascular clinical guidance and research into clinical implementation at the point of care. By combining ACC’s leadership in cardiovascular science and education with OpenEvidence’s advanced generative artificial intelligence (AI) technology, clinicians will have access to the latest relevant and actionable medical evidence to support shared decision-making with their patients.
“At the American College of Cardiology, our mission is to transform ...
2025-11-07
A new molecule developed by researchers at Oregon Health & Science University offers a promising avenue to treat intractable cases of triple-negative breast cancer — a form of cancer that is notoriously aggressive and lacks effective treatments.
In a study published today in the journal Cell Reports Medicine, researchers describe the effect of a molecule known as SU212 to inhibit an enzyme that is critical to cancer progression. The research was conducted in a humanized mouse model.
“It’s an important step forward to treat triple-negative breast cancer,” said senior author Sanjay V. Malhotra, Ph.D., co-director of the Center for Experimental ...
2025-11-07
Identifying ways that we can optimize Borderline Personality Disorder (BPD) treatment and prevention is an important public health priority. One area for further research is the relationship between sleep and BPD. Disrupted sleep is closely linked to key BPD features, and prior research has found a range of sleep problems among people with BPD. The Brain & Behavior Research Foundation (BBRF) will host a free webinar, “Evaluating the Potential of a Sleep Intervention Among Youth at High-Risk for Borderline Personality Disorder” on Tuesday, November 11, 2025, at 2:00 pm ET. In this webinar, Erin A. Kaufman, Ph.D., Assistant Professor in the Department ...
LAST 30 PRESS RELEASES:
[Press-News.org] Trial analysis reveals almost all adults with hypertensive chronic kidney disease would benefit from intensive blood pressure lowering
